Canton Strategic Holdings, Inc. (CNTN)
NASDAQ: CNTN · Real-Time Price · USD
3.350
-0.190 (-5.37%)
At close: Jun 18, 2026, 4:00 PM EDT
3.390
+0.040 (1.19%)
After-hours: Jun 18, 2026, 7:33 PM EDT
Canton Strategic Holdings Market Cap
Canton Strategic Holdings has a market cap or net worth of $233.85 million as of June 18, 2026. Its market cap has increased by 5,476.31% in one year.
Market Cap
233.85M
Enterprise Value
192.31M
1-Year Change
5,476.31%
Ranking
Category
Stock Price
$3.35
Market Cap Chart
Since January 12, 2022, Canton Strategic Holdings's market cap has increased from $32.56M to $233.85M, an increase of 618.15%. That is a compound annual growth rate of 56.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 233.85M | 111.76% |
| Dec 31, 2025 | 110.43M | 2,713.07% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -86.20% |
| Jan 12, 2022 | 32.56M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fate Therapeutics | 243.61M |
| Sol-Gel Technologies | 243.41M |
| Foghorn Therapeutics | 242.49M |
| Orchestra BioMed Holdings | 238.92M |
| AC Immune | 238.08M |
| Cybin | 233.67M |
| NervGen Pharma | 233.65M |
| Codexis | 233.60M |